Skip to main content
Year archive

SUPHA PHARMACHEM LIMITED — 2023 filings

All 61 regulatory filings released by SUPHA PHARMACHEM LIMITED (539561) in 2023, sourced directly from the official regulator.

61 Filings
2023 Period
2023 filings (61)
Filing Released Lang
Intimation of Closure of Trading Window pursuant to the provisions of SEBI(Prohibition of Insider Trading) Regulation, 2015
Regulatory Filings
2023-12-28 English
Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulation, 2015, we are enclosing intimation letter regarding loss ....
Regulatory Filings
2023-12-22 English
Pursuant to Regulation 39(3) 0f Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are enclosing intimation letter regarding loss ....
Regulatory Filings
2023-12-21 English
Clarification on Price Movement
Regulatory Filings
2023-12-18 English
Pursuant to Regulation 39(3) of Securities Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, We are enclosing intimation letter regarding loss ....
Regulatory Filings
2023-12-04 English
The Company has appointed Mrs. Dhwani Desai (ICSI Membership No. A63688) as a Company Secretary & Compliance Officer of the Company w.e.f. 20.11.2023.
Regulatory Filings
2023-11-21 English
Newspaper clipping regarding publication of Unaudited Financial Results for the quarter and half year ended September 30, 2023.
Regulatory Filings
2023-11-13 English
Unaudited Financial Results for the quarter and half year ending 30.09.2023
Regulatory Filings
2023-11-11 English
Board Meeting Outcome for Unaudited Financial Results For The Quarter And Half Year Ended 30.09.2023
Regulatory Filings
2023-11-11 English
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11/11/2023 ,inter alia, to consider and approve the Unaudited Financial Results ....
Regulatory Filings
2023-11-04 English
Certificate under Regulation 74(5) of SEBI DP Regulation, 2018 for the quarter ended 30th September, 2023
Regulatory Filings
2023-10-21 English
Intimation of Closure of Trading Window pursuant to the provisions of SEBI(Prohibition of Insider Trading) Regulation, 2015.
Regulatory Filings
2023-09-30 English
Resignation of Ms.Ashvini Dhuri(Membership No.A66051), as a Company Secretary & Compliance Officer of the Company.
Regulatory Filings
2023-09-08 English
With reference to our letter dated August 24, 2023, we would like to inform you that the Company has issued the duplicate share certificate in lieu of the share certificate lost by the shareholder.
Regulatory Filings
2023-09-06 English
Intimation under Regulation 30 of SEBI (LODR) Regulations 2015- Resignation of Whole Time Director.
Regulatory Filings
2023-09-05 English
Intimation under Regulation 30 of SEBI (LODR)Regulations 2015- Change in Directorate.
Regulatory Filings
2023-09-05 English
Outcome of the Board Meeting held on 05.09.2023
Regulatory Filings
2023-09-05 English
Please find enclosed herewith Copy of Letter sent to the shareholders holding shares in physical form, requesting them to provide their demat account details to the Company or Skyline Financial ....
Regulatory Filings
2023-08-29 English
Pursuant to Regulation 30 of SEBI (Listing Obligations & Disclosure Requirements)Regulations, 2015, as amended read with SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD-1/P/CIR/2023/37 dated ....
Regulatory Filings
2023-08-28 English
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/09/2023 ,inter alia, to consider and approve Remedium Lifecare Limited ....
Regulatory Filings
2023-08-26 English
Pursuant to Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations 2015, we would like to inform you that the Company ....
Regulatory Filings
2023-08-24 English
With reference to the captioned subject,we would like to inform you that Remedium Lifecare Limited has received NEW ISINfrom CDSL and NSDL pursuant to Subdivision/Stock Split of Face Value ....
Regulatory Filings
2023-08-23 English
Newspaper Clippings regarding publication of Unaudited Financial Results for the quarter ended June 30, 2023.
Regulatory Filings
2023-08-14 English
Results for the Quarter ended June 30, 2023.
Regulatory Filings
2023-08-12 English
Outcome of Board Meeting held on Saturday, August 12, 2023.
Regulatory Filings
2023-08-12 English
The Company has fixed Friday, September 01, 2023 as the Record Date for the purpose of ascertaining the names of the Shareholders who would be entitled to receive 2(Two) Equity Shares of ....
Regulatory Filings
2023-08-08 English
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 ,inter alia, to consider and approve the Un-Audited Financial ....
Regulatory Filings
2023-08-03 English
Intimation pursuant to regulation 30 of the SEBI (LODR) Regulation 2015 Regarding receipt of "Best Returns to the Investors Award" at Brandscouncil Ratings & Medilinks India Awards 2023 ....
Regulatory Filings
2023-08-01 English
We wish to inform you that our Company, Remedium Lifecare Limited ("the Company") in its Board Meeting held on July 31, 2023 have allotted 64,80,000 Equity Shares of Rs.10/-each as fully ....
Regulatory Filings
2023-07-31 English
Regulations 30 and 44 read with Schedule III of SEBI LODR Regulations 2015 showing revised format of Voting Result alongwith Scrutinizer''s Report.
Regulatory Filings
2023-07-21 English
Scrutinizer Report and E- Voting Result for 34th Annual General Meeting held on 20.07.2023.
Regulatory Filings
2023-07-20 English
Outcome of 34th AGM held on 20.07.2023.
Regulatory Filings
2023-07-20 English
Certificate under Regulation 74(5)of SEBI (DP) Regulations, 2018 for the quarter ended June 30, 2023.
Regulatory Filings
2023-07-08 English
Non-Applicability of Reg 57(5) of SEBI (LODR) Regulations, 2015 for the quarter ended June 2023.
Regulatory Filings
2023-07-04 English
Intimation of Closure of Trading Window pursuant to the provisions of SEBI (Prohibition of Insider Trading)Regulations, 2015.
Regulatory Filings
2023-06-30 English
Newspaper Publication mentioning procedure of E-voting for the 34th AGM.
Regulatory Filings
2023-06-28 English
Annual Report for the F.Y. 2022-23.
Regulatory Filings
2023-06-27 English
Newspaper Advertisement for 34th Annual General Meeting - Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2023-06-26 English
34th Annual General Meeting (AGM) of the Company will be held on Thursday, 20th July, 2023 at 11.00 am through VC/OAVM. Book Closure: From Friday 14th July, 2023 to Thursday 20th July, ....
Regulatory Filings
2023-06-26 English
34th Annual General Meeting (AGM) of the Company will be held on Thursday, 20th July, 2023 at 11.00 a.m. (IST) through Video Conferencing (VC) / Other Audio Visual Means (OAVM
Regulatory Filings
2023-06-26 English
In terms of Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements), Regulations 2015, as amended, we inform you that Remedium Lifecare Limited ('the Company') has fixed ....
Regulatory Filings
2023-06-23 English
Remedium Lifecare Ltd has informed BSE that the Board of Directors of the Company at their meeting held on 23/06/2023 ,inter alia, had considered and approved the: 1. Issue of Bonus ....
Regulatory Filings
2023-06-23 English
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/06/2023 ,inter alia, to consider and approve 1. issue of Bonus Shares ....
Regulatory Filings
2023-06-14 English
News Paper Clipping regarding publication of audited Financial Results for the 4th quarter and year ended on 31.03.2023.
Regulatory Filings
2023-06-01 English
The Board of Directors of the company at their meeting held on 30.05.2023, has approved the shifting of the registered office of the company from existing address at Office No. 601, Hyde ....
Regulatory Filings
2023-05-31 English
The Board of Directors of the Company in its meeting held on 30th May, 2023, had taken up the discussion regarding status of approval for the Scheme of amalgamation between MVK Lifesciences ....
Regulatory Filings
2023-05-30 English
Results for the Quarter and Year ended 31.03.2023
Regulatory Filings
2023-05-30 English
Outcome of Board Meeting held on 30.05.2023
Regulatory Filings
2023-05-30 English
Annual Secretarial Compliance Report of Remedium Lifecare Limited for the year ended 31st March, 2023.
Regulatory Filings
2023-05-29 English
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 ,inter alia, to consider and approve the Audited Financial Results ....
Regulatory Filings
2023-05-23 English
Compliance Certificate under Regulation 40 (9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015
Regulatory Filings
2023-04-25 English
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. Sr. No. Particulars Details ....
Regulatory Filings
2023-04-20 English
Compliance Certificate pursuant to Regulation 7(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 for the year ended 31.03.2023
Regulatory Filings
2023-04-19 English
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended March 31, 2023
Regulatory Filings
2023-04-11 English
Intimation of closure of Trading Window pursuant to provisions of SEBI (Prohibition of Insider Trading) Regulations, 2015
Regulatory Filings
2023-03-31 English
News Paper Clippings in respect of Unaudited Financial Results for the 3rd quarter and nine months ended 31.12.2022.
Regulatory Filings
2023-02-09 English
Unaudited Financial Results for the quarter and nine months ended 31.12.2022
Regulatory Filings
2023-02-07 English
The Board of Directors of the Company at its meeting held on 7th February, 2023 has approved the unaudited Standalone Financial Results for the Quarter and Nine Months Ended 31st December 2022.
Regulatory Filings
2023-02-07 English
Remedium Lifecare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2023 ,inter alia, to consider and approve the un-audited standalone ....
Regulatory Filings
2023-01-30 English
Clarification on Price Movement
Regulatory Filings
2023-01-24 English
Certificate under Regulation 74(5) of SEBI (DP) Regulations, 2018 for the quarter ended December 31, 2022.
Regulatory Filings
2023-01-14 English